Cargando…

Incidence and Risk Factors of Reinfection with HCV after Treatment in People Living with HIV

Infection with hepatitis C virus (HCV) does not induce protective immunity, and re-exposure to HCV can reinfect the population engaging in high-risk behavior. An increasing incidence of acute hepatitis C infection in people living with HIV (PLWH) has been described in recent years. This retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Chien-Yu, Ku, Shin-Yen, Lin, Yi-Chun, Chen, Cheng-Pin, Cheng, Shu-Hsing, Lin, I-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874599/ https://www.ncbi.nlm.nih.gov/pubmed/35216032 http://dx.doi.org/10.3390/v14020439

Ejemplares similares

Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial
por: Lin, Yi-Chun, et al.
Publicado: (2019)

Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
por: Liu, Chen-Hua, et al.
Publicado: (2022)

An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
por: Estrada, Josue Antonio, et al.
Publicado: (2022)

Safety and Immunogenicity of a Heterologous Booster of Protein Subunit Vaccine MVC-COV1901 after Two Doses of Adenoviral Vector Vaccine AZD1222
por: Cheng, Shu-Hsing, et al.
Publicado: (2022)

Predicting Emotional Valence of People Living with the Human Immunodeficiency Virus Using Daily Voice Clips: A Preliminary Study
por: Lin, Ray F., et al.
Publicado: (2021)

Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile
por: Dalla, Emiliano, et al.
Publicado: (2022)

Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter Study
por: Sun, Hsin-Yun, et al.
Publicado: (2023)

Incidence and molecular epidemiology of hepatitis C virus reinfection in prisons in Catalonia, Spain (Re-HCV study)
por: Saludes, Verónica, et al.
Publicado: (2023)

A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
por: Cheng, Shu-Hsing, et al.
Publicado: (2022)

Herpes zoster associated with stroke incidence in people living with human immunodeficiency virus: a nested case–control study
por: Ku, Han-Chang, et al.
Publicado: (2023)

Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS
por: Yen, Yung-Feng, et al.
Publicado: (2019)

Author Correction: Incidence and molecular epidemiology of hepatitis C virus reinfection in prisons in Catalonia, Spain (Re-HCV study)
por: Saludes, Verónica, et al.
Publicado: (2023)

Incidence of recent HCV infection among persons seeking voluntary counselling and testing for HIV and sexually transmitted infections in Taiwan
por: Su, Yi-Ching, et al.
Publicado: (2014)

Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCV
por: Taylor, Bryn C., et al.
Publicado: (2020)

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates
por: Lens, Sabela, et al.
Publicado: (2022)

Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study
por: Lin, Shih-Yi, et al.
Publicado: (2017)

Clinical validation of an automated reverse transcription-insulated isothermal PCR assay for the detection of severe acute respiratory syndrome coronavirus 2
por: Chang, Pai-Ling, et al.
Publicado: (2021)

Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects
por: Mazouz, Sabrina, et al.
Publicado: (2022)

Transcriptomic Assay of CD8(+) T Cells in Treatment-Naïve HIV, HCV-Mono-Infected and HIV/HCV-Co-Infected Chinese
por: Zhao, Jin, et al.
Publicado: (2012)

HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam
por: Molès, Jean-Pierre, et al.
Publicado: (2020)

Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
por: Cheng, Chien-Yu, et al.
Publicado: (2020)

Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
por: Liou, Bo-Huang, et al.
Publicado: (2021)

A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response
por: Lin, Yi-Chun, et al.
Publicado: (2020)

2355. Incidence of Omicron Variant Reinfection and Reduction of Reinfection Risk After Coronavirus Disease 2019 Vaccination in Children
por: Ikuse, Tatsuki, et al.
Publicado: (2023)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
por: Liu, Hung-Yin, et al.
Publicado: (2021)

Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants
por: Chen, Cheng-Pin, et al.
Publicado: (2022)

Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up
por: Lin, Kuan-Yin, et al.
Publicado: (2022)

445. High HCV Treatment Success among People Living with HIV - Kyrgyzstan, 2018-2021
por: Kyzy, Nasyat Kemelbek, et al.
Publicado: (2022)

Influence of the Type of Bone Cement Used in Two-Stage Exchange Arthroplasty for Chronic Periarticular Joint Infection on the Spacer Replacement and Reinfection Rate
por: Chang, Meng-Wei, et al.
Publicado: (2023)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
por: Huang, Chung-Feng, et al.
Publicado: (2021)

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
por: Chang, Te-Sheng, et al.
Publicado: (2023)

Hepatitis C microelimination among people living with HIV in Taiwan
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
por: Cheng, Pin-Nan, et al.
Publicado: (2019)

Successful Treatment of a Reinfected Liver Graft Because of Receipt of a HCV-Positive Kidney
por: Azhari, Hassan, et al.
Publicado: (2020)

Incidence of HIV and HCV in people who inject drugs: a systematic and meta-analysis review protocol
por: Sharhani, Asaad, et al.
Publicado: (2021)

Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin
por: Sasaki, Reina, et al.
Publicado: (2016)

Screening of differentially expressed gene in HIV/HCV co-infected patients
por: Yang, zhengrong, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8ge2t2obn0aahg50p6qmje63o3